State Street Health Care Select Sector SPDR ETF (XLV)
NYSEARCA: XLVState Street Investment ManagementHealthETFUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
XLV chart
Full chartKey facts
- Expense ratio
- 0.08%
- Assets (AUM)
- $49.10B
- Dividend yield
- 1.38%
- Holdings
- 10
- Inception
- Dec 16, 1998
- Issuer
- State Street Investment Management
- Index tracked
- —
- Category
- Health
- 52-week range
- 141.97 – 192.32
- Volume / Avg
- 18.02M / 9.50M
- Beta
- —
- Previous close
- 177.46
XLV ETF today
The State Street Health Care Select Sector SPDR ETF (XLV) is an exchange-traded fund from State Street Investment Management in the Health category. It charges an expense ratio of 0.08%, or $8.00 per year on a $10,000 investment, and manages $49.10 billion in assets. Its largest holding is Eli Lilly and Co (LLY) at 16.88% of assets, and the top 10 positions make up 61.4% of the portfolio out of 10 holdings.
XLV is up 14.5% year to date and has gained 14.6% over the past 12 months; over five years its price has changed +34.3%. The fund's trailing dividend yield is 1.38%. XLV launched on Dec 16, 1998.
Summary generated from market data by MetaCap's automated system. Methodology
XLV top 10 holdings
| # | Holding | Weight |
|---|---|---|
| 1 | LLYEli Lilly and Co | 16.88% |
| 2 | JNJJohnson & Johnson | 9.80% |
| 3 | ABBVAbbVie Inc | 7.76% |
| 4 | MRKMerck & Co Inc | 5.49% |
| 5 | UNHUnitedHealth Group Inc | 5.44% |
| 6 | TMOThermo Fisher Scientific Inc | 3.84% |
| 7 | AMGNAmgen Inc | 3.75% |
| 8 | GILDGilead Sciences Inc | 3.15% |
| 9 | ABTAbbott Laboratories | 2.73% |
| 10 | PFEPfizer Inc | 2.59% |
Top 10 holdings: 61.4% of assets.
XLV performance
1 week
-6.15%
1 month
-0.95%
3 months
+1.50%
6 months
+18.25%
Year to date
+14.50%
1 year
+14.64%
3 years
+35.16%
5 years
+34.30%
XLV price return, excluding dividends.
ETFs similar to XLV
XLV news
All XLV news- Healthcare ETFs Shine as Investors Rotate Out of TechNasdaqLLY, MRNA, XLV, BBH
- Notable ETF Outflow Detected - XLV, ABT, PFE, ISRGNasdaqXLV, ABT, PFE, ISRG
- Where These 4 Sector ETFs Stand Heading Into Year-EndNasdaqXLK, XLF, XLE, XLV
- This ETF Has Gained 23% This Year. Is It Still Worth Buying in 2026?Nasdaq
- December 31st Options Now Available For Select Sector SPDR Trust - State Street Health Care Select Sector SPDR ETF (XLV)NasdaqXLV, STT
- ETFs in Spotlight as FDA Vision Loss Warning Meets Lilly's Sleep Apnea WinNasdaqXLV, VHT, IHE, PPH
- XLV, ISRG, DHR, VRTX: ETF Inflow AlertNasdaqXLV, ISRG, DHR, VRTX
- AI and Tech Selloff Heats Up: Buy Big Pharma Stock LLY as a Safe Haven?NasdaqLLY, XLV, XBI
XLV ETF FAQ
What is the XLV price today?
XLV last traded at $177.24 as of Nov 20, 4:00 PM EST, down 0.12% on the day.
What is XLV's expense ratio?
XLV has an expense ratio of 0.08%, which works out to about $8.00 per year for every $10,000 invested.
What are XLV's top holdings?
XLV's largest holdings are Eli Lilly and Co (16.88%), Johnson & Johnson (9.80%), AbbVie Inc (7.76%), Merck & Co Inc (5.49%), UnitedHealth Group Inc (5.44%). The top 10 make up 61.4% of the fund.
Does XLV pay a dividend?
Yes. XLV has a trailing dividend yield of 1.38% and pays quarterly distributions; the most recent was $0.642 per share with an ex-dividend date of Sep 21, 2026.
How big is XLV?
XLV has about $49.10 billion in assets under management spread across 10 holdings.